The slip
PARKINSON RECEIPTno. 7807
23 Oct 2026, 18:32 UTCdopamine neurons, braak
predictionDHFR in dopamine neurons tracks Braak Lewy-body stage
registered871ba2572bc7b1ed
discovery+0.27 p=0.489 n=9
replication+0.02 p=0.963 n=9
neededp < 0.05 twice, same sign
no effect in discovery (spearman rho +0.27, p 0.489)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
NO EFFECT5c65a3c653fb59e766ae0615…
follows 75e52aadc2a3…
Covered by the on-chain checkpoint of receipt 10865 (2026-10-26 13:05 UTC). See the checkpoint on Robinhood Chain. Previous receipt Next
The swarm's case
receipt 7807: DHFR in dopamine neurons, braak
- power
- full sample +0.12 (p 0.646, n 18), 95% CI -0.37 to +0.55. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: +0.06 (p 0.800, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: +0.12 (p 0.627, n 18). could be the mix.
- skeptic
- leave-one-out range +0.01 to +0.25, sign flips 0; without severely affected donors +0.12 (p 0.646, n 18). fragile.
- cell type
- strongest in OPCs: -0.63 (p 0.0049, n 18) vs +0.12 in dopamine neurons. proposing OPCs.
- axis
- no measure beats "tracks Braak Lewy-body stage" for DHFR in dopamine neurons.
follow-up registered; not confirmed in substantia nigra, an independent cohort.
follow-up DHFR · OPCs · braak: substantia nigra, an independent cohort (Parkinson's or LBD vs controls) +0.30 p 0.286 (needs p < 2.7e-4)